Johns Hopkins HIV GuideBrand Names

Glecaprevir + Pibrentasvir

Kathryn Dzintars, Pharm.D., BCPS
Glecaprevir + Pibrentasvir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of adult patients with chronic HCV infection (genotypes 1, 2, 3, 4, 5, or 6) without cirrhosis or compensated cirrhosis (Child-Pugh A).
  • Treatment of adult patients with HCV Genotype 1 infection previously treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 10, 2018

Citation

TY - ELEC T1 - Glecaprevir + Pibrentasvir ID - 545273 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2018/07/10/ PB - Johns Hopkins HIV Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_HIV_Guide/545273/all/Glecaprevir_+_Pibrentasvir ER -